# TECTONIC CAD IVL IDE Study

Study · id `cardio:ct-nct06885177` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06885177](<https://clinicaltrials.gov/study/NCT06885177>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06885177

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 335 participants.

## Technical summary

Registry record NCT06885177. Allocation not applicable; no masking; primary purpose treatment. Start 2025-04-01 (actual); primary completion 2026-05-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 335 participants (enrolled count; ClinicalTrials.gov record NCT06885177, source copy `cardio:ctgov-nct06885177-2026-09-08`, retrieved 2026-10-26)
- Started: 2025-04-01 (actual) (ClinicalTrials.gov record NCT06885177, source copy `cardio:ctgov-nct06885177-2026-09-08`, retrieved 2026-10-26)
- Primary completion: 2026-05-15 (actual) (ClinicalTrials.gov record NCT06885177, source copy `cardio:ctgov-nct06885177-2026-09-08`, retrieved 2026-10-26)
- Completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT06885177, source copy `cardio:ctgov-nct06885177-2026-09-08`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06885177, source copy `cardio:ctgov-nct06885177-2026-09-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06885177-2026-09-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: TECTONIC CAD IVL IDE Study
- Acronym: TECTONIC
- Condition: Coronary Artery Calcification
- Condition: Coronary Artery Disease
- Condition: Stenotic Coronary Lesion
- Intervention (Device): Experimental
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: b10e045dddf30238d2ce518e600fda3e4dbd211e54bab5cc22973f1d89792f0d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
